missing translation for 'onlineSavingsMsg'
Få mere at vide
Få mere at vide
Thyrotropin-Releasing Hormone, TRC
Tekniske data
Tekniske data
| Kemisk navn eller materiale | D-His-Protirelin |
| CAS | 24305-27-9 |
| Molekylær formel | C16 H22 N6 O4 |
| Mængde | 5 mg |
| Synonym | Protirelin, 5-Oxo-l-prolyl-l-histidyl-l-prolinamide, L-Prolinamide, 5-oxo-L-prolyl-L-histidyl-, Thyrotropin-releasing factor (8CI), (Pyro)-L-glutamic acid-L-histidine-L-proline-NH2, 252: PN: WO2010033207 SEQID: 378 claimed protein, 83: PN: US20090175821 PAGE: 403 claimed protein, Abbott 38579, Antepan, FDA 1725, L-Pyroglutamyl-L-histidyl-L-prolinamide, L-Pyroglutamyl-L-histidyl-L-proline amide, Lopremone, Prem, Protirelin, Relefact TRH, Rifathyroin, Rifotironin, Ro 8-6270/9, Stimu TSH, Synthetic TRF, Synthetic TRH, Synthetic TSH-releasing factor, Synthetic TSH-releasing hormone, Synthetic thyrotropin-releasing factor, Synthetic thyrotropin-releasing hormone, TRF, TRH, TSH-RF, TSH-releasing factor, TSH-releasing hormone, Thypinone, Thyrefact, Thyroid releasing hormone, Thyroid-stimulating hormone-releasing factor, Thyroliberin, Thyrotropic hormone-releasing factor, Thyrotropic hormone-releasing hormone, Thyrotropic releasing hormone, Thyrotropic-releasing factor, Thyrotropin-releasing hormone |
| InChI formel | InChI=1S/C16H22N6O4/c17-14(24)12-2-1-5-22(12)16(26)11(6-9-7-18-8-19-9)21-15(25)10-3-4-13(23)20-10/h7-8,10-12H,1-6H2,(H2,17,24)(H,18,19)(H,20,23)(H,21,25)/t10-,11-,12-/m0/s1 |
| SMIL | NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H]3CCC(=O)N3 |
| IUPAC navn | (2S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide |
| Molekylvægt (g/mol) | 362.38 |
| Formel vægt | 362.1703 |
Produkttitel
Ved at klikke på Send, anerkender du, at du kan blive kontaktet af Fisher Scientific med hensyn til den feedback, du har givet i denne formular. Vi deler ikke dine oplysninger til andre formål. Alle angivne kontaktoplysninger skal også vedligeholdes i overensstemmelse med vores Privatlivspolitik.
Ser du en mulighed for forbedring?